CARL

17.2300.06%
JD

Jonathan D. Root

Independent Director

Dr. Jonathan D. Root, also known as Jon, M.D., M.B.A. is an Independent Director of Omada Health, Inc. from January 2013. Dr. Root was Director at Sparrow Pharmaceuticals, Inc until October 2025. He served as Director at Contego Medical, Inc. since 2023 until 2025. He was a Director of ARS Pharmaceuticals, Inc. until November 8, 2022. He serves as Independent Director of Carlsmed, Inc. since December 2020. He served as a Director of Silverback Therapeutics, Inc. since March 2020 until November 08, 2022. Dr. Root serves as Director at Ribon Therapeutics, Inc. since November 2015. Dr. Root served as an Independent Director of eFFECTOR Therapeutics, Inc. since August 2021 until February 2022. Dr. Root has been a General Partner at U.S. Venture Partners VIII, L.P. since 1998. Dr. Root joined the U.S. Venture Partners in July 1995. Dr. Root serves as an Independent Director of Edgewise Therapeutics, Inc. since August 2019. Dr. Root has served as the Managing Member of Presidio Management Group XI, L.L.C. and of the several general partnerships for the other U.S. Venture Partners’ venture capital funds, since January 1998. He is General Partner of USVP Management Company, LLC from 1997. Jon evaluates investments in the medical field. He serves on the board of Silverback Therapeutics, Inc. Prior to USVP, he spent many years in clinical practice and on the faculty and clinical staff at The New York Hospital-Cornell Medical Center, where he was an Assistant Professor of Neurology. Dr. Root served as Director of OncoMed Pharmaceuticals, Inc. since August 2004 until its merger with Mereo BioPharma Group plc until April 23, 2019. He is a Director of Omada Health, Okami Medical, Inc., Carlsmed, Inc. and Route 92 Medical, Inc. He serves as a Director of Sequent Medical, Inc., Inceptus Medical LLC, Allergenics, Embol-X, Ascenta, Lutonix, Inc., Integrated Vascular Systems, Altus Biologics and CanDo.com. Dr. Root serves as a Director of Articulinx, Cleave Therapeutics, Inc., effector Therapeutics and Castlight Health. He was an Independent Director of Inari Medical, Inc. since September 2011 until February 2025. He served as a Director of the Neurology-Neurosurgery Intensive Care Unit at The New York Hospital-Cornell Medical Center. Dr. Root served an Outside Director at CryoVascular Systems, Inc. He served as a Director at Ilypsa, Inc. since July 19, 2005. Dr. Root served as a Director at Raven biotechnologies and also served as a Director at Onyx Therapeutics, Inc., Allergenics, Altus Pharmaceuticals Inc., from September 2001 to April 01, 2009. He served as a Director at MicroVention, Inc. He is Board certified in Neurology. Dr. Root maintains relationships with leading medical schools on both coasts and enjoys helping entrepreneurs make meaningful connections. He helps entrepreneurs connect with leading specialists to gain input on product design issues. He is a Director of HealthJoy. Dr. Root is a Ewing Marion Kauffman Fellow in Venture Capital and Entrepreneurship. Dr. Root serves on the boards of directors of several privately held healthcare technology companies. Dr. Root served as Director at Nuvaira, Inc. until July 2025. Dr. Root holds an M.D. from the University of Florida College of Medicine, an M.B.A. from Columbia Business School and an A.B. in Economics and Government from Dartmouth College.

Positions